Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography-Reference-Cited by-同舟云学术

Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography

Published:2019-03 Issue:2 Volume:9 Page:207-214
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Rout Gyanranjan,Nayak Baibaswata,Patel Arpan H.,Gunjan Deepak,Singh Vishwajeet,Kedia Saurabh,Shalimar

Funder

Department of Health Research, Ministry of Health and Family Welfare, Government of India

Publisher

Elsevier BV

Subject

Hepatology

Reference28 articles.

1. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study;Davila;Gastroenterology,2004

2. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review;Falade-Nwulia;Ann Intern Med,2017

3. Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection;Gupta;J Viral Hepat,2018

4. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C;Poynard;J Hepatol,2013

5. Liver stiffness decreases rapidly in response to successful hepatitis C treatment and then plateaus;Chekuri;PLOS ONE,2016

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Liver Steatosis on Interleukin and Growth Factors Kinetics during Chronic Hepatitis C Treatment;Journal of Clinical Medicine;2024-08-16

2. Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD;Hepatology International;2024-08-08

3. Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007–2021: a nationwide, multicentre, retrospective cohort study;eClinicalMedicine;2024-07

4. Hepatocellular carcinoma after direct‐acting antivirals for hepatitis C is associated with KIR‐HLA types predicting weak NK cell‐mediated immunity;European Journal of Immunology;2024-05-03

5. Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals;Journal of Gastroenterology;2024-04-13